166 related articles for article (PubMed ID: 21235742)
1. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.
Davies PG; Venkatesh B; Morgan TJ; Presneill JJ; Kruger PS; Thomas BJ; Roberts MS; Mundy J
Crit Care; 2011; 15(1):R21. PubMed ID: 21235742
[TBL] [Abstract][Full Text] [Related]
2. Sodium reduction during cardiopulmonary bypass: Plasma-Lyte 148 versus trial fluid as pump primes.
Morgan TJ; Presneill JJ; Davies PG; Power G; Venkatesh B
Crit Care Resusc; 2015 Dec; 17(4):263-7. PubMed ID: 26640062
[TBL] [Abstract][Full Text] [Related]
3. Plasma-Lyte 148 vs. Hartmann's solution for cardiopulmonary bypass pump prime: a prospective double-blind randomized trial.
Weinberg L; Chiam E; Hooper J; Liskaser F; Hawkins AK; Massie D; Ellis A; Tan CO; Story D; Bellomo R
Perfusion; 2018 May; 33(4):310-319. PubMed ID: 29144182
[TBL] [Abstract][Full Text] [Related]
4. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study.
Morgan TJ; Power G; Venkatesh B; Jones MA
Anaesth Intensive Care; 2008 Nov; 36(6):822-9. PubMed ID: 19115651
[TBL] [Abstract][Full Text] [Related]
5. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
Williams V; Jayashree M; Nallasamy K; Dayal D; Rawat A
Crit Care; 2020 Jan; 24(1):1. PubMed ID: 31898531
[TBL] [Abstract][Full Text] [Related]
6. A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients.
Verma B; Luethi N; Cioccari L; Lloyd-Donald P; Crisman M; Eastwood G; Orford N; French C; Bellomo R; Martensson J
Crit Care Resusc; 2016 Sep; 18(3):205-12. PubMed ID: 27604335
[TBL] [Abstract][Full Text] [Related]
7. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
Crit Care Resusc; 2017 Sep; 19(3):239-246. PubMed ID: 28866974
[TBL] [Abstract][Full Text] [Related]
8. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
[TBL] [Abstract][Full Text] [Related]
9. Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution.
Sanchez AM; Wooldridge TA; Boerboom LE; Olinger GN; Almassi GH; Rusch NJ
J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1445-53. PubMed ID: 8196386
[TBL] [Abstract][Full Text] [Related]
10. Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO).
Hayes W; Laing E; Foley C; Pankhurst L; Thomas H; Hume-Smith H; Marks S; Kessaris N; Bryant WA; Spiridou A; Wray J; Peters MJ
BMJ Open; 2022 Mar; 12(3):e055595. PubMed ID: 35288387
[TBL] [Abstract][Full Text] [Related]
11. Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.
Petraitiene R; Petraitis V; Witt JR; Durkin MM; Bacher JD; Wheat LJ; Walsh TJ
J Clin Microbiol; 2011 Dec; 49(12):4330-2. PubMed ID: 21976760
[TBL] [Abstract][Full Text] [Related]
12. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.
Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Henderson SJ; Mackle DM; McArthur CJ; Mehrtens JE; Myburgh JA; McGuinness SP; Psirides AJ; Young PJ
Crit Care Resusc; 2014 Dec; 16(4):274-9. PubMed ID: 25437221
[TBL] [Abstract][Full Text] [Related]
13. Peri-operative effect of major gastrointestinal surgery on serum magnesium.
Sanchez-Capuchino A; McConachie I
Anaesthesia; 1994 Oct; 49(10):912-4. PubMed ID: 7802196
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
15. 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial.
Raman S; Schibler A; Marsney RL; Trnka P; Kennedy M; Mattke A; Gibbons K; Schlapbach LJ
Trials; 2021 Jul; 22(1):427. PubMed ID: 34217337
[TBL] [Abstract][Full Text] [Related]
16. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis.
Chua HR; Venkatesh B; Stachowski E; Schneider AG; Perkins K; Ladanyi S; Kruger P; Bellomo R
J Crit Care; 2012 Apr; 27(2):138-45. PubMed ID: 22440386
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules.
el Habbal MH; Smith LJ; Elliott MJ; Strobel S
Cardiovasc Res; 1997 Jan; 33(1):209-15. PubMed ID: 9059546
[TBL] [Abstract][Full Text] [Related]
18. Physico-chemical stability of Plasma-Lyte 148® and Plasma-Lyte 148® + 5% Glucose with eight common intravenous medications.
Dawson R; Wignell A; Cooling P; Barrett D; Vyas H; Davies P
Paediatr Anaesth; 2019 Feb; 29(2):186-192. PubMed ID: 30472805
[TBL] [Abstract][Full Text] [Related]
19. The Plasma-Lyte 148 versus Saline (PLUS) study protocol amendment.
Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
Crit Care Resusc; 2019 Dec; 21(4):284-86. PubMed ID: 31778635
[No Abstract] [Full Text] [Related]
20. A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
Hayes WN; Laing E; Brown R; Silsby L; Smith L; Thomas H; Kaloyirou F; Sharma R; Griffiths J; Hume-Smith H; Marks SD; Kessaris N; Christian M; Dudley J; Shenoy M; Malina M; Muorah M; Ware N; Yadav P; Reynolds B; Bryant W; Spiridou A; Wray J; Peters MJ
Kidney Int; 2024 Feb; 105(2):364-375. PubMed ID: 37914088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
